{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:29:55Z","timestamp":1718152195687},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,11]]},"DOI":"10.7759\/cureus.62123","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:59:20Z","timestamp":1718092760000},"source":"Crossref","is-referenced-by-count":0,"title":["Adrenal Mass and Hypokalaemia: The Zebra Among Horses"],"prefix":"10.7759","author":[{"given":"Zsuzsanna","family":"Reti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laszlo","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radu  M","family":"Neagoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda","family":"Kolcsar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht M","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, et al.. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023, 189:G1-G42. 10.1093\/ejendo\/lvad066","journal-title":"Eur J Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder JW","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, et al.. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016, 101:1889-916. 10.1210\/jc.2015-4061","journal-title":"J Clin Endocrinol Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199101000-00004","article-title":"A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience","volume":"70","author":"Stein PP","year":"1991","unstructured":"Stein PP, Black HR. A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. Medicine (Baltimore). 1991, 70:46-66. 10.1097\/00005792-199101000-00004","journal-title":"Medicine (Baltimore)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4158\/EP.2.5.326","article-title":"Hypokalemia in a patient with pheochromocytoma","volume":"2","author":"Molison MS","year":"1996","unstructured":"Molison MS, Barbagallo J, Mohapatra C, Streeten DH, Numann PJ. Hypokalemia in a patient with pheochromocytoma. Endocr Pract. 1996, 2:326-9. 10.4158\/EP.2.5.326","journal-title":"Endocr Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1479-2354(02)00005-6","article-title":"Phaeochromocytoma: a case study","volume":"6","author":"Foggo J","year":"2003","unstructured":"Foggo J. Phaeochromocytoma: a case study. Clinical Chiropractic. 2003, 6:50-4. 10.1016\/S1479-2354(02)00005-6","journal-title":"Clinical Chiropractic"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.1993.tb00228.x","article-title":"Effects of catecholamines on plasma potassium: the role of alpha- and beta-adrenoceptors","volume":"7","author":"Moratinos J","year":"1993","unstructured":"Moratinos J, Reverte M. Effects of catecholamines on plasma potassium: the role of alpha- and beta-adrenoceptors. Fundam Clin Pharmacol. 1993, 7:143-53. 10.1111\/j.1472-8206.1993.tb00228.x","journal-title":"Fundam Clin Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-117179","article-title":"Excessive catecholamine secretion and the activation of the renin-angiotensin-aldosterone-system in patients with pheochromocytoma: a single center experience and overview of the literature","volume":"49","author":"Haase M","year":"2017","unstructured":"Haase M, Dringenberg T, Allelein S, Willenberg HS, Schott M. Excessive catecholamine secretion and the activation of the renin-angiotensin-aldosterone-system in patients with pheochromocytoma: a single center experience and overview of the literature. Horm Metab Res. 2017, 49:748-54. 10.1055\/s-0043-117179","journal-title":"Horm Metab Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7686373","article-title":"Hyperkalemia induced by the sequential administration of metoprolol and carvedilol","volume":"2018","author":"Barold SS","year":"2018","unstructured":"Barold SS, Upton S. Hyperkalemia induced by the sequential administration of metoprolol and carvedilol. Case Rep Cardiol. 2018, 2018:7686373. 10.1155\/2018\/7686373","journal-title":"Case Rep Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00015385.2020.1799573","article-title":"Low serum potassium levels are associated with the risk of atrial fibrillation","volume":"76","author":"Farah R","year":"2021","unstructured":"Farah R, Nassar M, Aboraya B, Nseir W. Low serum potassium levels are associated with the risk of atrial fibrillation. Acta Cardiol. 2021, 76:887-90. 10.1080\/00015385.2020.1799573","journal-title":"Acta Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.4997\/JRCPE.2013.312","article-title":"Management of hyperkalaemia","volume":"43","author":"Maxwell AP","year":"2013","unstructured":"Maxwell AP, Linden K, O'Donnell S, Hamilton PK, McVeigh GE. Management of hyperkalaemia. J R Coll Physicians Edinb. 2013, 43:246-51.","journal-title":"J R Coll Physicians Edinb"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200309000-00020","article-title":"Diabetes as a marker of pheochromocytoma in hypertensive patients","volume":"21","author":"La Batide-Alanore A","year":"2003","unstructured":"La Batide-Alanore A, Chatellier G, Plouin PF. Diabetes as a marker of pheochromocytoma in hypertensive patients. J Hypertens. 2003, 21:1703-7. 10.1097\/00004872-200309000-00020","journal-title":"J Hypertens"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030871","article-title":"Diagnosis and complications of Cushing's syndrome: a consensus statement","volume":"88","author":"Arnaldi G","year":"2003","unstructured":"Arnaldi G, Angeli A, Atkinson AB, et al.. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab. 2003, 88:5593-602. 10.1210\/jc.2003-030871","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.crvasa.2014.06.004","article-title":"High-dose spironolactone changes renin and aldosterone levels in acutely decompensated heart failure","volume":"56","author":"Ferreira JP","year":"2014","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H. High-dose spironolactone changes renin and aldosterone levels in acutely decompensated heart failure. Cor Vasa. 2014, 56:e463-70. 10.1016\/j.crvasa.2014.06.004","journal-title":"Cor Vasa"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.14871","article-title":"Effects of ramipril on the aldosterone\/renin ratio and the aldosterone\/angiotensin II ratio in patients with primary aldosteronism","volume":"76","author":"Guo Z","year":"2020","unstructured":"Guo Z, Poglitsch M, Cowley D, et al.. Effects of ramipril on the aldosterone\/renin ratio and the aldosterone\/angiotensin II ratio in patients with primary aldosteronism. Hypertension. 2020, 76:488-96. 10.1161\/HYPERTENSIONAHA.120.14871","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.228","article-title":"Aldosterone\/direct renin concentration ratio versus aldosterone\/plasma renin activity for diagnosis of primary hyperaldosteronism: case presentation","volume":"5","author":"Shanik MH","year":"2021","unstructured":"Shanik MH, Romao IJ, Velayati S. Aldosterone\/direct renin concentration ratio versus aldosterone\/plasma renin activity for diagnosis of primary hyperaldosteronism: case presentation. J Endocr Soc. 2021, 5:A113-4. 10.1210\/jendso\/bvab048.228","journal-title":"J Endocr Soc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/1043-2760(93)90035-d","article-title":"Pheochromocytoma: 1926-1993","volume":"4","author":"Young WF","year":"1993","unstructured":"Young WF. Pheochromocytoma: 1926-1993. Trends Endocrinol Metab. 1993, 4:122-7. 10.1016\/1043-2760(93)90035-d","journal-title":"Trends Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa008","article-title":"Adrenal incidentaloma","volume":"41","author":"Sherlock M","year":"2020","unstructured":"Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, Stewart PM. Adrenal incidentaloma. Endocr Rev. 2020, 41:775-820. 10.1210\/endrev\/bnaa008","journal-title":"Endocr Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting S","year":"2022","unstructured":"N\u00f6lting S, Bechmann N, Taieb D, et al.. Personalized management of pheochromocytoma and paraganglioma. Endocr Rev. 2022, 43:199-239. 10.1210\/endrev\/bnab019","journal-title":"Endocr Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-0645","article-title":"Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells","volume":"149","author":"Ziegler CG","year":"2008","unstructured":"Ziegler CG, Sicard F, Lattke P, Bornstein SR, Ehrhart-Bornstein M, Krug AW. Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells. Endocrinology. 2008, 149:320-8. 10.1210\/en.2007-0645","journal-title":"Endocrinology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-016-0121-y","article-title":"Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series","volume":"16","author":"Tahir A","year":"2016","unstructured":"Tahir A, McLaughlin K, Kline G. Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series. BMC Endocr Disord. 2016, 16:43. 10.1186\/s12902-016-0121-y","journal-title":"BMC Endocr Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/259753-adrenal-mass-and-hypokalaemia-the-zebra-among-horses","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T07:59:24Z","timestamp":1718092764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/259753-adrenal-mass-and-hypokalaemia-the-zebra-among-horses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.62123","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,11]]}}}